menu
    • menu

    Company profile for Orbus Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. We at Orbus are committed to bringing innovative products to the extremely under served patients affected by rare diseases. We are focused and passionate about bringing a more positive outcome to patients facing life threatening or significantly life altering diseases. Currently Orbus Therapeut...
    Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. We at Orbus are committed to bringing innovative products to the extremely under served patients affected by rare diseases. We are focused and passionate about bringing a more positive outcome to patients facing life threatening or significantly life altering diseases. Currently Orbus Therapeutics is working to develop and commercialize eflornithine in North America.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orbus TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2479 E. Bayshore Road, Suite 105 | Palo Alto, CA 94303
    Telephone
    Telephone
    650-656-9440
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.orbustherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orbus Therapeutics Showcases Phase 3 STELLAR Study Results
    Orbus Therapeutics Showcases Phase 3 STELLAR Study Results

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3192045/36946/en/Orbus-Therapeutics-Highlights-Phase-3-STELLAR-Clinical-Study-Results-Showing-Clinically-Meaningful-Benefits-in-Rare-Brain-Tumor-at-Society-for-Neuro-Oncology-SNO-Annual-Meeting.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Orbus Therapeutics Presents Phase 3 STELLAR Trial Results
    Orbus Therapeutics Presents Phase 3 STELLAR Trial Results

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184342/36946/en/Orbus-Therapeutics-Announces-Oral-Presentation-of-Updated-Results-With-Blinded-Independent-Central-Review-from-the-Phase-3-STELLAR-Clinical-Trial-at-the-Society-for-Neuro-Oncology-.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Orbus Therapeutics names Jason Levin, Co-founder, COO President
    Orbus Therapeutics names Jason Levin, Co-founder, COO President

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3033883/36946/en/Orbus-Therapeutics-Appoints-Jason-Levin-Co-founder-and-COO-to-President.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share
    Eflornithine Show Clinically Improve In Recurrent Astrocytoma Survival
    Eflornithine Show Clinically Improve In Recurrent Astrocytoma Survival

    22 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/11/22/2986091/36946/en/Combination-of-Eflornithine-and-Lomustine-Demonstrates-Clinically-Meaningful-Improvements-in-Overall-Survival-OS-and-Progression-Free-Survival-PFS-in-Patients-with-Recurrent-Astroc.html

    GLOBENEWSWIRE
    22 Nov 2024
    Share Share
    Orbus Announces First Patient Enrolled in Ph 1 Study in Diagnosed Glioblastoma
    Orbus Announces First Patient Enrolled in Ph 1 Study in Diagnosed Glioblastoma

    06 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/06/2738464/36946/en/Orbus-Therapeutics-Announces-First-Patient-Enrolled-in-Phase-1-Clinical-Study-in-Newly-Diagnosed-Glioblastoma.html

    GLOBENEWSWIRE
    06 Sep 2023
    Share Share
    Orbus Enters Agreement to Treatment of Rare Pediatric Syndrome with Eflornithine
    Orbus Enters Agreement to Treatment of Rare Pediatric Syndrome with Eflornithine

    10 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/10/2586093/36946/en/Orbus-Therapeutics-Enters-Exclusive-License-Agreement-for-Intellectual-Property-Related-to-Treatment-of-Rare-Pediatric-Syndrome-with-Eflornithine.html

    GLOBENEWSWIRE
    10 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search